EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
January 31, 2023 -2.652
October 31, 2022 -4.503
July 31, 2022 -4.591
April 30, 2022 -3.492
January 31, 2022 -5.544
October 31, 2021 -5.508
July 31, 2021 -6.628
April 30, 2021 -5.564
January 31, 2021 -8.212
October 31, 2020 -10.87
July 31, 2020 -8.560
April 30, 2020 -9.909
January 31, 2020 -28.00
October 31, 2019 -20.17
July 31, 2019 -15.52
April 30, 2019 -227.20
January 31, 2019 -29.16
October 31, 2018 -30.20
July 31, 2018 -50.60
April 30, 2018 -44.00
January 31, 2018 -68.20
October 31, 2017 -57.20
July 31, 2017 -60.02
April 30, 2017 -48.40
January 31, 2017 -59.40
Date Value
October 31, 2016 -63.80
July 31, 2016 -80.04
April 30, 2016 -81.40
January 31, 2016 -92.40
October 31, 2015 -103.40
July 31, 2015 -97.62
April 30, 2015 -105.60
January 31, 2015 -88.00
October 31, 2014 -88.00
July 31, 2014 -63.71
April 30, 2014 -88.00
January 31, 2014 -44.00
October 31, 2013 -44.00
July 31, 2013 -88.00
April 30, 2013 -44.00
January 31, 2013 -88.00
October 31, 2012 -88.00
July 31, 2012 -132.00
April 30, 2012 -44.00
January 31, 2012 -220.00
October 31, 2011 220.00
July 31, 2011 -220.00
April 30, 2011 -44.00
January 31, 2011 -0.0014
October 31, 2010 -0.0014

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.1822
Alnylam Pharmaceuticals, Inc. 1.207
Savara, Inc. -0.1587
Vericel Corp. 0.0422
Biogen, Inc. 0.6557